EW
VRTX icon

Evoke Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Evoke Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,485
Closed -$663K – 649
2026
Q1 		$663K Buy
1,485
+131
+10% +$61.1K 0.01% 352
2025
Q4 		$614K Buy
1,354
+342
+34% +$147K 0.01% 350
2025
Q3 		$396K Buy
1,012
+96
+10% +$40.1K 0.01% 426
2025
Q2 		$408K Sell
916
-257
-22% -$118K 0.01% 386
2025
Q1 		$569K Buy
1,173
+102
+10% +$47.5K 0.01% 256
2024
Q4 		$431K Buy
1,071
+83
+8% +$38.5K 0.01% 286
2024
Q3 		$459K Buy
+988
New +$475K 0.01% 266
2024
Q2 		– Sell
-943
Closed -$394K – 389
2024
Q1 		$394K Buy
+943
New +$399K 0.01% 294
2022
Q4 		– Sell
-166
Closed -$48K – 1125
2022
Q3 		$48K Hold
166
– – ﹤0.01% 523
2022
Q2 		$47K Sell
166
-8
-5% -$2.14K ﹤0.01% 526
2022
Q1 		$45K Buy
174
+43
+33% +$10.2K ﹤0.01% 540
2021
Q4 		$29K Hold
131
– – ﹤0.01% 616
2021
Q3 		$23K Sell
131
-6
-4% -$1.17K ﹤0.01% 620
2021
Q2 		$28K Sell
137
-42
-23% -$8.79K ﹤0.01% 599
2021
Q1 		$38K Buy
179
+36
+25% +$7.91K ﹤0.01% 487
2020
Q4 		$34K Buy
143
+8
+6% +$1.84K ﹤0.01% 422
2020
Q3 		$37K Hold
135
– – ﹤0.01% 398
2020
Q2 		$39K Sell
135
-3
-2% -$813 ﹤0.01% 382
2020
Q1 		$32.8K Sell
138
-313
-69% -$71.8K ﹤0.01% 377
2019
Q4 		$98.7K Sell
451
-46
-9% -$9.31K 0.01% 324
2019
Q3 		$84.2K Buy
+497
New +$87.9K 0.01% 398

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Evoke Wealth's VRTX Position: Q2 2026 in Review

Evoke Wealth sold out of Vertex Pharmaceuticals (VRTX) in Q2 2026, closing a stake of 1,485 shares — an estimated $663K sold.

Evoke Wealth first reported a position in VRTX in Q3 2019 and held it in 21 quarters. The position peaked at $663K in Q1 2026. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Evoke Wealth reported no remaining Vertex Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Evoke Wealth sold 1,485 Vertex Pharmaceuticals shares in Q2 2026, an estimated $663K.
  • Evoke Wealth first reported a position in Vertex Pharmaceuticals in Q3 2019 and held it in 21 quarters.
  • Evoke Wealth's Vertex Pharmaceuticals position peaked at $663K in Q1 2026.
  • 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Evoke Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.